In 2023, the animal antimicrobials and antibiotics market is to accumulate a market value of US$ 4,911.9 million. By 2033, this number is expected to expand to US$ 7,878.2 million, with a Compound Annual Growth Rate (CAGR) of 4.9%.
The demand for animal antimicrobials and antibiotics is on the rise during the forecast period due to the widespread use of several types of milk and meat products, especially in the Western diet.
Zoonotic illnesses and demand for animal-derived food products are also factors contributing to the rising demand for the products. Due to rising demand for pet insurance and rising expenditures for veterinary care, this market share for animal antimicrobials and antibiotics is expected to grow.
Explore our comprehensive Sample report on the Animal Antimicrobials and Antibiotics Market and unleash your growth potential! https://www.futuremarketinsights.com/reports/sample/rep-gb-11212
Animal antimicrobials and antibiotics market participants can expect tremendously rapid development thanks to the potential held by the untapped markets in China, India, and Brazil during the forecast period. The overall population of animals can also be seen to be on the rise, which is another great contributing factor.
In the realm of veterinary medicine, a silent revolution is underway – the Animal Antimicrobials and Antibiotics Market. While we often associate antibiotics with human health, these remarkable substances play a crucial role in safeguarding the well-being of our furry, feathered, and scaly companions too!
🦴 Pet Pharmaceuticals: From antibiotics for common infections to specialized antimicrobials, the market caters to the diverse health needs of our pets. It’s not just about curing ailments; it’s about ensuring our animal friends lead healthy, happy lives.
🐮 Livestock Lifesavers: Beyond pets, the industry impacts livestock too. Antibiotics help maintain the health of farm animals, ensuring the production of safe and abundant food supplies.
🌍 Global Guardians: As awareness about antibiotic resistance grows, the animal antimicrobial market strives to strike a balance between treatment and responsible use. It’s a global effort to protect both animal and human health.
🚀 Innovative Advancements: The market isn’t just about pills anymore. Innovations like probiotics, vaccines, and cutting-edge diagnostics are reshaping the landscape, promoting healthier animals and reducing the need for antibiotics.
🌱 Natural Alternatives: Nature often provides the best solutions. Herbal remedies and natural antimicrobial options are gaining traction, offering sustainable and eco-friendly choices for animal health.
📈 Market Growth: With a growing pet population and increasing awareness of animal health, the market shows no signs of slowing down. It’s not just about economics; it’s about ensuring our animal companions have access to the best care.
Buy now to gain access to detailed information about each segment: https://www.futuremarketinsights.com/checkout/11212
Key Takeaways:
- The United States holds a notable market share of 17.8% in the animal antimicrobials and antibiotics market in 2022, showcasing its significant role in the industry as a major consumer and contributor to the veterinary pharmaceutical sector.
- Germany, with a market share of 6.6%, demonstrates its participation in the animal antimicrobials and antibiotics market, emphasizing the country’s commitment to animal health and welfare through the use of appropriate pharmaceutical interventions.
- Japan’s market share in the animal antimicrobials and antibiotics market stands at 5.4% in 2022, reflecting the country’s focus on ensuring its livestock population’s well-being and disease management through the responsible use of antimicrobial products.
- Australia contributes to the animal antimicrobials and antibiotics market with a market share of 1.0% in 2022, emphasizing the country’s attention to animal health and its efforts to mitigate the impact of infectious diseases through the judicious use of antimicrobials.
- China exhibits a compound annual growth rate (CAGR) of 5.2% in the animal antimicrobials and antibiotics market, reflecting the country’s evolving livestock industry and the increasing demand for antimicrobial products to address animal health challenges and ensure food safety.
- India experiences a robust CAGR of 9.6% in the animal antimicrobials and antibiotics market, highlighting the country’s expanding livestock sector and the growing need for effective disease management and growth promotion in the animal farming industry.
- The United Kingdom showcases a CAGR of 5.9% in the animal antimicrobials and antibiotics market, indicating the country’s continuous efforts to promote responsible antimicrobial use, reduce the risk of antimicrobial resistance, and safeguard animal health and welfare in its agricultural practices.
Competitive Landscape
- Trianni Inc. (US) and Zoetis (US) have decided to work together on developing transgenic monoclonal antibody platforms for the discovery of innovative veterinary medications. This collaboration began in July 2020. The FDA approved Zoetis’ purchase of Marboquin (US).
- Elanco (US) and AgBiome worked together to provide nutritional health solutions for pigs in 2019.
- By balancing its food animal and companion animal divisions, Elanco Animal Health (US) announced in 2019 that it purchases Bayer’s Animal Health Business, boosting its own companion animal business and portfolio mix.
- In 2019, Sanofi (France) purchased the Animal Health division of Boehringer Ingelheim (Germany) (Merial), and Boehringer Ingelheim (Germany) (CHC) was bought by Sanofi. After acquiring Merial, BI became the second-largest animal health firm in the world.
Request Methodology for a Comprehensive Analysis! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-11212
Animal Antimicrobials and Antibiotics Market by Category
By Product Type:
- Tetracyclines
- Penicillins
- Sulfonamides
- Macrolides
- Aminoglycosides
- Lincosamides
- Fluoroquinolones
- Cephalosporins
- Other Antimicrobials and Antibiotics
By Animal Type:
- Companion Animals
- Food Producing Animals
By Mode of Delivery:
- Premixes
- Oral Powder
- Oral Solution
- Injection
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube